CareDx provided earnings guidance for fourth quarter ended December 31, 2023. For the quarter, the company expects revenue to be between $65 million and $66 million, a decrease of approximately 3% compared with $67.2 million in the third quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.56 USD | 0.00% | -9.03% | -37.00% |
Apr. 16 | CareDx Appoints John Hanna as CEO, President | MT |
Apr. 16 | CareDx, Inc Appoints John W. Hanna as Chief Executive Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.00% | 391M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-46.94% | 377M | |
+13.32% | 332M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- CareDx, Inc Provides Earnings Guidance for Fourth Quarter Ended December 31, 2023